Solstice Neurosciences

About:

Solstice Neurosciences is focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products.

Website: http://www.solsticeneuro.com

Top Investors: Highland Capital Partners, Oxford Bioscience Partners, Investor Growth Capital Limited, Thomas, McNerney & Partners, Morgan Stanley Venture Partners

Description:

Solstice Neurosciences is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice's first product named Myobloc® (rimabotulinumtoxinB) Injection in the U.S. and NeuroBloc® (Botulinum Toxin Type B) Injectable Solution in select overseas markets, represents the only botulinum toxin type B currently available to physicians and patients worldwide.